Biography and Research Information
OverviewAI-generated summary
Caroline G. Geels has focused on developing and evaluating noncontact diffuse reflectance spectroscopy for the rapid identification of infections in synovial fluid samples, as demonstrated in her 2024 publication. She also investigated the noninferiority of subcutaneous versus intravenous administration of casirivimab/imdevimab for outpatient treatment of SARS-CoV-2 in a real-world setting, publishing these findings in 2022. Geels has co-authored publications with researchers from the University of Arkansas at Fayetteville, including Samantha Robinson, Sheena CarlLee, and Sharon Reece, as well as Spencer Parnell from the University of Arkansas for Medical Sciences. Her scholarly output includes two publications with a total of two citations and an h-index of 1.
Metrics
- h-index: 1
- Publications: 2
- Citations: 2
Selected Publications
-
Noncontact Diffuse Reflectance Spectroscopy of Synovial Fluid Samples for Rapid Identification of Infections (2024)
-
Noninferiority of Subcutaneous Versus Intravenous Casirivimab/Imdevimab for Outpatient Treatment of SARS-CoV-2 in a Real-World Setting (2022)
Collaboration Network
Top Collaborators
- Noninferiority of Subcutaneous Versus Intravenous Casirivimab/Imdevimab for Outpatient Treatment of SARS-CoV-2 in a Real-World Setting
- Noncontact Diffuse Reflectance Spectroscopy of Synovial Fluid Samples for Rapid Identification of Infections
- Noninferiority of Subcutaneous Versus Intravenous Casirivimab/Imdevimab for Outpatient Treatment of SARS-CoV-2 in a Real-World Setting
- Noninferiority of Subcutaneous Versus Intravenous Casirivimab/Imdevimab for Outpatient Treatment of SARS-CoV-2 in a Real-World Setting
- Noninferiority of Subcutaneous Versus Intravenous Casirivimab/Imdevimab for Outpatient Treatment of SARS-CoV-2 in a Real-World Setting
- Noninferiority of Subcutaneous Versus Intravenous Casirivimab/Imdevimab for Outpatient Treatment of SARS-CoV-2 in a Real-World Setting
- Noninferiority of Subcutaneous Versus Intravenous Casirivimab/Imdevimab for Outpatient Treatment of SARS-CoV-2 in a Real-World Setting
- Noninferiority of Subcutaneous Versus Intravenous Casirivimab/Imdevimab for Outpatient Treatment of SARS-CoV-2 in a Real-World Setting
- Noninferiority of Subcutaneous Versus Intravenous Casirivimab/Imdevimab for Outpatient Treatment of SARS-CoV-2 in a Real-World Setting
- Noncontact Diffuse Reflectance Spectroscopy of Synovial Fluid Samples for Rapid Identification of Infections
- Noncontact Diffuse Reflectance Spectroscopy of Synovial Fluid Samples for Rapid Identification of Infections
- Noncontact Diffuse Reflectance Spectroscopy of Synovial Fluid Samples for Rapid Identification of Infections
- Noncontact Diffuse Reflectance Spectroscopy of Synovial Fluid Samples for Rapid Identification of Infections
- Noncontact Diffuse Reflectance Spectroscopy of Synovial Fluid Samples for Rapid Identification of Infections
Similar Researchers
Based on overlapping research topics